PANCREATIC CARCINOMA

This early-phase study tests a new drug called MGC028 in adults with advanced solid tumors (lung, bile duct, pancreas, or colon cancer) that have not responded to standard treatments. The main goals are to find a safe dose and see if the drug can shrink tumors or stop them from g…

This study tests a new drug called XNW28012 in people with advanced solid tumors (like pancreatic, ovarian, or cervical cancer) who have run out of standard options. The goal is to find a safe dose and see if the drug can shrink tumors. About 350 participants will take part in tw…

This study tests an experimental drug called patritumab deruxtecan in people with advanced solid tumors that have spread or cannot be removed. The drug targets a protein called HER3 found on some cancer cells. About 740 adults with various cancers like lung, breast, or melanoma w…

This study is testing a new blood test that looks for tiny particles called exosomes to find pancreatic cancer early. The goal is to see if this test can accurately detect the disease in 2000 adults, including those with and without cancer. If successful, it could lead to a simpl…

This study tests if giving the drug lanreotide before pancreatic surgery can prevent a common complication called a pancreatic fistula, where digestive fluids leak from the pancreas. About 274 people with pancreatic cancer or pre-cancerous lesions will be randomly assigned to rec…

This study tests whether giving cancer treatment at home is preferred over going to a clinic. It involves 27 adults with various cancers in the Florida Panhandle. The goal is to see if home care improves patient satisfaction and is safe.

This study looks back at 1,200 patients who had a breathing tube placed during general anesthesia for non-throat surgeries. Researchers want to find out how often throat injuries like hoarseness or sore throat happen, what factors increase the risk, and how patients recover. The …

This study looks at whether taking a blood sample from the vein that drains directly from a liver or pancreas tumor gives more useful genetic information than a standard arm vein sample. About 15 adults scheduled for a biopsy will provide both samples, and researchers will compar…

This study is testing new blood tests that look for signs of many different cancers at the same time. The goal is to see if these tests can find cancer early, when treatment works best. About 24,000 adults aged 45 to 75 who do not have cancer will take part. They will be placed i…

This study enrolls 30,000 people without pancreatic cancer but at higher-than-average risk due to family history or genetic mutations. Researchers will collect blood and tissue samples over time to find ways to detect pancreatic cancer earlier, when it may be more treatable. The …

This study compares two ways of monitoring pancreatic cysts: more frequent check-ups versus less frequent ones. The goal is to see which approach leads to better outcomes for patients. About 4,600 people aged 50 to 75 with pancreatic cysts will take part. The study does not test …